Which medication is given to high-risk preterm infants to prevent infection from RSV?

Prepare for the RNC-NICU Test with comprehensive flashcards and multiple-choice questions. Each query includes helpful hints and detailed explanations to boost your confidence and readiness. Start your journey to success now!

Multiple Choice

Which medication is given to high-risk preterm infants to prevent infection from RSV?

Explanation:
The main concept is preventing RSV illness in high‑risk preterm infants with a passive immunization approach. Palivizumab is a monoclonal antibody given by monthly injections during RSV season to provide immediate protection by binding the RSV F protein and neutralizing the virus, which reduces hospitalization risk. It is used specifically for prophylaxis, not as a vaccine that stimulates the infant’s own immune response. Ribavirin is an antiviral used to treat RSV infections in certain hospitalized infants, not for routine prevention. Interferon isn’t a standard RSV prophylaxis. Oseltamivir targets influenza, not RSV. Therefore, Palivizumab is the best choice for preventing RSV infection in these high‑risk infants.

The main concept is preventing RSV illness in high‑risk preterm infants with a passive immunization approach. Palivizumab is a monoclonal antibody given by monthly injections during RSV season to provide immediate protection by binding the RSV F protein and neutralizing the virus, which reduces hospitalization risk. It is used specifically for prophylaxis, not as a vaccine that stimulates the infant’s own immune response.

Ribavirin is an antiviral used to treat RSV infections in certain hospitalized infants, not for routine prevention. Interferon isn’t a standard RSV prophylaxis. Oseltamivir targets influenza, not RSV. Therefore, Palivizumab is the best choice for preventing RSV infection in these high‑risk infants.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy